ScoreWhy is Regeneron Pharmaceuticals, Inc. ?
1
High Management Efficiency with a high ROE of 23.74%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 11.04% and Operating profit at 0.69%
4
Flat results in Dec 25
- INTEREST(HY) At USD 31.5 MM has Grown at 29.63%
- ROCE(HY) Lowest at 14.87%
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.84 times
5
With ROE of 14.34%, it has a attractive valuation with a 2.65 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 10.47%, its profits have fallen by -2.5%
6
High Institutional Holdings at 89.09%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Regeneron Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Regeneron Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Regeneron Pharmaceuticals, Inc.
3.65%
-0.53
41.08%
S&P 500
20.78%
0.92
19.35%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.04%
EBIT Growth (5y)
0.69%
EBIT to Interest (avg)
87.72
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.45
Tax Ratio
9.73%
Dividend Payout Ratio
8.49%
Pledged Shares
0
Institutional Holding
89.09%
ROCE (avg)
33.12%
ROE (avg)
23.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.65
EV to EBIT
18.67
EV to EBITDA
16.54
EV to Capital Employed
3.02
EV to Sales
5.20
PEG Ratio
NA
Dividend Yield
0.36%
ROCE (Latest)
16.19%
ROE (Latest)
14.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 4,978.9 MM
DIVIDEND PAYOUT RATIO(Y)
Highest at 11.2%
RAW MATERIAL COST(Y)
Fallen by 0.66% (YoY
DIVIDEND PER SHARE(HY)
Highest at USD 2.4
NET SALES(Q)
Highest at USD 3,884.3 MM
-5What is not working for the Company
INTEREST(HY)
At USD 31.5 MM has Grown at 29.63%
ROCE(HY)
Lowest at 14.87%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.84 times
Here's what is working for Regeneron Pharmaceuticals, Inc.
Operating Cash Flow
Highest at USD 4,978.9 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 3,884.3 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Dividend per share
Highest at USD 2.4
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Dividend Payout Ratio
Highest at 11.2%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by 0.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 145 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Regeneron Pharmaceuticals, Inc.
Interest
At USD 31.5 MM has Grown at 29.63%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Inventory Turnover Ratio
Lowest at 0.84 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Non Operating Income
Highest at USD 0.49 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
